First Header Logo Second Header Logo

Edward Levine

Concepts (567)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Peritoneal Neoplasms
98
2020
256
19.180
Why?
Hyperthermia, Induced
86
2020
236
14.410
Why?
Chemotherapy, Cancer, Regional Perfusion
56
2020
154
9.530
Why?
Appendiceal Neoplasms
32
2020
99
8.730
Why?
Adenocarcinoma
48
2019
298
6.240
Why?
Antineoplastic Combined Chemotherapy Protocols
49
2020
442
6.170
Why?
Combined Modality Therapy
85
2020
550
4.480
Why?
Breast Neoplasms
45
2021
767
4.450
Why?
Antineoplastic Agents
31
2020
595
4.400
Why?
Stomach Neoplasms
29
2019
113
3.980
Why?
Sentinel Lymph Node Biopsy
24
2020
71
3.770
Why?
Survival Rate
81
2020
892
3.520
Why?
Colorectal Neoplasms
22
2020
220
3.470
Why?
Middle Aged
189
2021
11843
3.270
Why?
Neoplasm Staging
69
2021
458
3.240
Why?
Neoplasm Recurrence, Local
32
2020
372
3.160
Why?
Humans
267
2021
32284
2.970
Why?
Female
210
2021
19954
2.880
Why?
Carcinoma
16
2016
92
2.870
Why?
Mitomycin
21
2020
50
2.860
Why?
Adult
139
2021
9263
2.810
Why?
Melanoma
14
2019
166
2.720
Why?
Aged
144
2021
10257
2.710
Why?
Prognosis
71
2020
1529
2.510
Why?
Quality of Life
15
2020
971
2.460
Why?
Adenocarcinoma, Mucinous
6
2020
28
2.450
Why?
Retrospective Studies
98
2020
3612
2.420
Why?
Male
163
2020
19434
2.410
Why?
Postoperative Complications
26
2018
818
2.260
Why?
Follow-Up Studies
66
2021
2238
2.120
Why?
Skin Neoplasms
11
2019
220
2.100
Why?
Treatment Outcome
68
2021
3410
2.100
Why?
Aged, 80 and over
71
2021
3896
1.990
Why?
Adrenocortical Carcinoma
16
2019
35
1.940
Why?
Adrenal Cortex Neoplasms
16
2019
36
1.940
Why?
Lymph Nodes
14
2019
114
1.890
Why?
Colonic Neoplasms
9
2016
70
1.810
Why?
Chemotherapy, Adjuvant
31
2019
185
1.770
Why?
Prospective Studies
44
2021
2320
1.760
Why?
Mesothelioma
10
2019
33
1.730
Why?
Gastrectomy
22
2018
70
1.690
Why?
Neoplasms
14
2020
763
1.540
Why?
Liver Neoplasms
12
2018
164
1.530
Why?
Mastectomy
14
2020
59
1.520
Why?
Peritoneum
8
2020
32
1.520
Why?
Esophageal Neoplasms
6
2014
39
1.480
Why?
Infusions, Parenteral
22
2016
63
1.470
Why?
Lymphatic Metastasis
29
2020
169
1.390
Why?
Lymph Node Excision
18
2019
94
1.350
Why?
Radiopharmaceuticals
9
2010
93
1.140
Why?
Young Adult
31
2020
2652
1.140
Why?
Radiography, Thoracic
2
2019
40
1.130
Why?
Pseudomyxoma Peritonei
7
2014
13
1.120
Why?
Mammaplasty
6
2013
26
0.950
Why?
Antibiotics, Antineoplastic
8
2011
69
0.930
Why?
Fluorodeoxyglucose F18
7
2010
49
0.930
Why?
Survival Analysis
30
2017
478
0.910
Why?
Sarcoma
6
2020
82
0.840
Why?
Organoplatinum Compounds
5
2013
41
0.840
Why?
Jejunal Neoplasms
3
2013
6
0.830
Why?
Rectal Neoplasms
4
2013
19
0.830
Why?
Adrenalectomy
8
2018
33
0.800
Why?
Positron-Emission Tomography
6
2010
167
0.760
Why?
Disease-Free Survival
22
2018
322
0.750
Why?
Predictive Value of Tests
14
2019
880
0.740
Why?
Mastectomy, Segmental
7
2021
25
0.730
Why?
Duodenal Neoplasms
2
2013
7
0.720
Why?
Blood Cell Count
2
2019
27
0.710
Why?
Morbidity
10
2017
98
0.690
Why?
Mutation
6
2017
497
0.690
Why?
Neoadjuvant Therapy
6
2019
62
0.670
Why?
Carcinoma, Lobular
4
2015
12
0.670
Why?
Neoplasm Invasiveness
12
2017
180
0.650
Why?
Abdominal Neoplasms
3
2014
13
0.630
Why?
Depression
4
2020
427
0.630
Why?
Surgical Wound Infection
3
2019
100
0.620
Why?
Negative-Pressure Wound Therapy
2
2019
38
0.620
Why?
Ovarian Neoplasms
5
2016
84
0.620
Why?
Ileal Neoplasms
2
2013
4
0.620
Why?
Pancreatectomy
5
2019
25
0.610
Why?
Gynecology
1
2019
18
0.590
Why?
Hepatectomy
7
2018
57
0.590
Why?
Gene Expression Profiling
4
2020
325
0.590
Why?
Workplace
1
2019
37
0.590
Why?
Obstetrics
1
2019
25
0.590
Why?
Proportional Hazards Models
14
2020
773
0.580
Why?
Severity of Illness Index
4
2018
851
0.580
Why?
Liver Function Tests
1
2019
22
0.580
Why?
Adolescent
21
2018
3521
0.570
Why?
Pancreatic Neoplasms
6
2019
131
0.570
Why?
Esophagectomy
4
2014
15
0.560
Why?
Carcinoma, Merkel Cell
2
2009
9
0.560
Why?
Burnout, Professional
1
2019
54
0.560
Why?
Caregivers
1
2020
114
0.560
Why?
Carcinoma, Intraductal, Noninfiltrating
5
2020
19
0.550
Why?
United States
32
2019
4079
0.540
Why?
Rosaniline Dyes
6
2009
19
0.540
Why?
Carcinoma, Ductal, Breast
5
2020
31
0.530
Why?
Enteral Nutrition
2
2015
29
0.530
Why?
Neoplasms, Glandular and Epithelial
3
2016
9
0.520
Why?
Retroperitoneal Neoplasms
3
2019
19
0.510
Why?
Digestive System Neoplasms
1
2017
3
0.500
Why?
Laparotomy
1
2017
30
0.490
Why?
Cohort Studies
14
2018
1840
0.490
Why?
Sensitivity and Specificity
13
2018
555
0.490
Why?
Coloring Agents
4
2009
31
0.490
Why?
Carboplatin
4
2013
42
0.470
Why?
Length of Stay
8
2019
321
0.460
Why?
Leiomyosarcoma
3
2010
10
0.430
Why?
Intraoperative Care
7
2015
52
0.420
Why?
Genetic Testing
2
2013
90
0.420
Why?
Angiogenesis Inhibitors
1
2014
38
0.420
Why?
Thalidomide
1
2014
32
0.420
Why?
Registries
9
2018
294
0.410
Why?
Radiotherapy, Adjuvant
13
2019
83
0.410
Why?
Multivariate Analysis
10
2016
650
0.410
Why?
Cytological Techniques
2
2011
16
0.410
Why?
Urinary Bladder Neoplasms
2
2017
189
0.390
Why?
Adjuvants, Immunologic
2
2011
60
0.380
Why?
Breast Diseases
1
2013
3
0.380
Why?
Nipples
1
2013
3
0.380
Why?
Databases, Factual
11
2018
368
0.380
Why?
Health Status
5
2019
356
0.380
Why?
Gene Expression Regulation, Neoplastic
3
2009
257
0.370
Why?
Pancreaticoduodenectomy
2
2019
23
0.370
Why?
Intraoperative Period
6
2011
43
0.360
Why?
BCG Vaccine
1
2011
8
0.350
Why?
Mastectomy, Modified Radical
1
2011
2
0.350
Why?
Breast
2
2020
63
0.350
Why?
Biopsy, Needle
4
2005
93
0.350
Why?
Genes, BRCA2
2
2011
10
0.340
Why?
Cisplatin
6
2014
77
0.340
Why?
Adenomatous Polyposis Coli
1
2011
7
0.340
Why?
Lung Neoplasms
5
2017
422
0.330
Why?
Secondary Prevention
1
2011
75
0.330
Why?
Societies, Medical
2
2016
153
0.330
Why?
Adenoma
1
2011
35
0.330
Why?
Biopsy
3
2020
249
0.320
Why?
Histocytological Preparation Techniques
1
2010
3
0.320
Why?
Incidence
9
2019
1244
0.320
Why?
Medical Oncology
1
2011
90
0.320
Why?
Thoracoscopy
1
2010
11
0.320
Why?
Technetium Tc 99m Sulfur Colloid
2
2009
5
0.310
Why?
Organoids
3
2020
101
0.310
Why?
Nutrition Assessment
2
2014
48
0.300
Why?
Colectomy
3
2014
30
0.300
Why?
Mammography
4
2005
41
0.300
Why?
Tomography, Emission-Computed
3
2005
27
0.300
Why?
Subcutaneous Tissue
1
2009
6
0.290
Why?
Neoplasms, Connective Tissue
1
2009
3
0.290
Why?
Drug Screening Assays, Antitumor
2
2019
56
0.290
Why?
Diagnostic Tests, Routine
2
2019
24
0.290
Why?
Disease Progression
7
2017
590
0.290
Why?
Uterine Neoplasms
1
2009
26
0.290
Why?
Neuroendocrine Tumors
2
2019
19
0.280
Why?
Disease Management
2
2020
129
0.280
Why?
Yoga
1
2009
51
0.270
Why?
Risk Factors
13
2017
3938
0.270
Why?
Pregnancy Complications, Neoplastic
2
2011
4
0.270
Why?
Pleural Neoplasms
2
2007
8
0.270
Why?
Fertility Agents, Female
1
2007
5
0.260
Why?
Frozen Sections
4
2014
19
0.260
Why?
Leuprolide
1
2007
5
0.260
Why?
Breast Neoplasms, Male
1
2007
11
0.260
Why?
Neoplasm Metastasis
9
2019
222
0.260
Why?
Biopsy, Fine-Needle
3
2007
62
0.260
Why?
Microwaves
1
2007
8
0.260
Why?
Electrocoagulation
1
2007
11
0.260
Why?
Catheter Ablation
3
2004
113
0.260
Why?
Polymorphism, Genetic
4
2011
179
0.250
Why?
Deoxycytidine
5
2013
57
0.250
Why?
Mental Health
2
2019
113
0.250
Why?
Models, Biological
2
2019
403
0.250
Why?
Logistic Models
7
2018
743
0.250
Why?
Pilot Projects
7
2019
554
0.250
Why?
Carcinoma, Squamous Cell
4
2012
156
0.250
Why?
Focal Nodular Hyperplasia
1
2006
3
0.240
Why?
Hemoperitoneum
1
2006
4
0.240
Why?
Patient Readmission
3
2016
135
0.240
Why?
Activities of Daily Living
4
2011
246
0.240
Why?
Child
7
2014
2446
0.240
Why?
Obesity
1
2013
1108
0.240
Why?
European Continental Ancestry Group
4
2017
1076
0.240
Why?
Blood Transfusion
2
2017
69
0.230
Why?
Feasibility Studies
6
2019
309
0.230
Why?
North Carolina
8
2015
1299
0.230
Why?
Head and Neck Neoplasms
1
2007
137
0.230
Why?
Reproducibility of Results
6
2020
755
0.230
Why?
DNA Repair
4
2014
55
0.230
Why?
Nomograms
2
2016
35
0.220
Why?
Preoperative Care
3
2013
126
0.220
Why?
Jejunostomy
2
2015
8
0.220
Why?
Receptor, erbB-2
2
2014
63
0.220
Why?
Gallbladder Neoplasms
2
2015
35
0.220
Why?
Intussusception
1
2004
2
0.210
Why?
Liposarcoma, Myxoid
1
2004
2
0.210
Why?
Colonoscopy
2
2019
45
0.210
Why?
Reoperation
5
2017
247
0.210
Why?
Genetic Markers
2
2015
124
0.200
Why?
Ethnic Groups
3
2016
450
0.200
Why?
Cluster Analysis
2
2015
121
0.200
Why?
Genes, erbB-2
1
2003
7
0.200
Why?
Age Factors
8
2017
1179
0.200
Why?
Prostatic Neoplasms
2
2013
489
0.200
Why?
Blood Platelets
2
2015
59
0.200
Why?
Vascular Surgical Procedures
3
2015
85
0.200
Why?
Parathyroid Neoplasms
1
2003
7
0.200
Why?
Time Factors
8
2020
2196
0.200
Why?
Camptothecin
2
2005
45
0.190
Why?
Neutrophils
2
2015
120
0.190
Why?
Patient Selection
4
2020
272
0.190
Why?
Surgical Flaps
3
2013
75
0.190
Why?
Interferon-alpha
1
2003
68
0.190
Why?
Pregnancy
3
2019
963
0.190
Why?
Genes, p53
3
2017
22
0.180
Why?
DNA, Neoplasm
2
2017
52
0.180
Why?
Cytodiagnosis
3
2011
15
0.180
Why?
Clinical Trials as Topic
3
2009
312
0.180
Why?
Injections, Intraperitoneal
5
2014
45
0.180
Why?
Lymphocytes
2
2015
56
0.180
Why?
Diagnosis, Differential
6
2020
502
0.170
Why?
Health Services Accessibility
3
2019
242
0.170
Why?
Hospital Mortality
3
2017
197
0.170
Why?
Consensus
2
2013
86
0.160
Why?
GTP Phosphohydrolases
1
2020
7
0.160
Why?
Unnecessary Procedures
1
2020
16
0.160
Why?
Anus Neoplasms
2
2012
13
0.160
Why?
Extremities
1
2020
51
0.160
Why?
Precancerous Conditions
1
2020
23
0.160
Why?
Proto-Oncogene Proteins p21(ras)
1
2020
16
0.160
Why?
Pelvis
2
2018
67
0.160
Why?
Necrosis
2
2013
52
0.160
Why?
Health Care Rationing
1
2020
11
0.160
Why?
Quality Assurance, Health Care
1
2020
72
0.160
Why?
Immune System Phenomena
1
2020
5
0.160
Why?
Oncogenes
1
2020
14
0.150
Why?
Radiotherapy Dosage
4
2010
106
0.150
Why?
Randomized Controlled Trials as Topic
3
2013
548
0.150
Why?
Cost of Illness
1
2020
72
0.150
Why?
Remote Consultation
1
2019
14
0.150
Why?
Hospitals, University
1
2019
27
0.150
Why?
Leukocytes, Mononuclear
1
2019
54
0.150
Why?
Splenectomy
3
2017
22
0.150
Why?
Peritoneal Lavage
1
2019
2
0.150
Why?
Quality of Health Care
1
2020
148
0.150
Why?
Immunohistochemistry
4
2008
544
0.150
Why?
Tissue Array Analysis
1
2019
34
0.150
Why?
Leadership
1
2019
45
0.150
Why?
Odds Ratio
7
2015
455
0.150
Why?
Self Efficacy
1
2019
74
0.140
Why?
Endoscopy, Digestive System
1
2019
11
0.140
Why?
Seroma
1
2019
5
0.140
Why?
Laparoscopy
2
2019
184
0.140
Why?
Antineoplastic Agents, Hormonal
3
2015
40
0.140
Why?
Myeloid Cells
1
2019
39
0.140
Why?
Surgical Wound Dehiscence
1
2019
12
0.140
Why?
Gastrointestinal Hemorrhage
1
2019
20
0.140
Why?
Lower Gastrointestinal Tract
1
2018
3
0.140
Why?
Membrane Proteins
1
2020
243
0.140
Why?
Cell Proliferation
2
2018
599
0.140
Why?
Pneumonia, Viral
1
2020
98
0.140
Why?
Coronavirus Infections
1
2020
95
0.140
Why?
Vascular Neoplasms
2
2010
12
0.140
Why?
Digestive System Surgical Procedures
2
2011
21
0.140
Why?
Intestinal Neoplasms
1
2018
3
0.140
Why?
Practice Guidelines as Topic
2
2013
394
0.140
Why?
Vena Cava, Inferior
2
2010
28
0.140
Why?
Urachus
1
2017
3
0.130
Why?
Intensive Care Units
2
2015
121
0.130
Why?
Skin Diseases
1
2019
135
0.130
Why?
Appendectomy
1
2018
19
0.130
Why?
Anesthesia, Conduction
1
2018
24
0.130
Why?
Risk Assessment
7
2017
1424
0.130
Why?
Dermatology
1
2019
157
0.130
Why?
Diaphragm
2
2014
37
0.130
Why?
Animals
5
2019
8165
0.130
Why?
Hospital Charges
1
2017
15
0.130
Why?
Neoplastic Cells, Circulating
1
2017
23
0.130
Why?
Crohn Disease
1
2017
33
0.120
Why?
Medicaid
2
2008
101
0.120
Why?
Intestinal Perforation
1
2016
10
0.120
Why?
African Americans
3
2017
1335
0.120
Why?
Cross Infection
1
2017
57
0.120
Why?
Decision Support Techniques
1
2018
131
0.120
Why?
Lymphedema
2
2017
6
0.120
Why?
Vomiting
2
2014
20
0.120
Why?
Emotions
1
2016
55
0.120
Why?
Nausea
2
2014
50
0.120
Why?
Taxoids
2
2013
50
0.120
Why?
Mitotane
1
2015
2
0.120
Why?
Gastric Stump
1
2015
2
0.120
Why?
Linitis Plastica
1
2015
2
0.120
Why?
Gastroenterostomy
1
2015
2
0.120
Why?
Anastomosis, Roux-en-Y
1
2015
6
0.120
Why?
Biliary Tract Surgical Procedures
1
2015
7
0.110
Why?
Genetic Predisposition to Disease
3
2014
821
0.110
Why?
Bile Ducts
1
2015
19
0.110
Why?
Peritoneal Stomata
1
2015
3
0.110
Why?
Bile Duct Neoplasms
1
2015
33
0.110
Why?
Tumor Cells, Cultured
4
2018
165
0.110
Why?
Forecasting
1
2016
144
0.110
Why?
Patient Admission
1
2015
54
0.110
Why?
Pain Measurement
1
2016
340
0.110
Why?
Blood Vessels
1
2015
58
0.110
Why?
Anemia
1
2015
50
0.110
Why?
Carcinoma, Signet Ring Cell
1
2014
6
0.110
Why?
Skilled Nursing Facilities
1
2014
13
0.110
Why?
Anastomosis, Surgical
2
2015
58
0.110
Why?
Drug Therapy, Combination
2
2013
293
0.110
Why?
Myocardial Infarction
1
2019
466
0.110
Why?
Gastrointestinal Stromal Tumors
1
2014
12
0.110
Why?
Protein-Tyrosine Kinases
1
2014
36
0.110
Why?
Abdominal Cavity
1
2014
6
0.110
Why?
Gastrostomy
1
2014
17
0.100
Why?
Thromboembolism
1
2014
33
0.100
Why?
Gastrointestinal Neoplasms
1
2014
35
0.100
Why?
Nervous System Diseases
1
2014
46
0.100
Why?
Appendix
1
2014
6
0.100
Why?
Neoplasm, Residual
3
2016
22
0.100
Why?
Thiosulfates
1
2013
3
0.100
Why?
Reconstructive Surgical Procedures
1
2015
191
0.100
Why?
Axilla
3
2020
18
0.100
Why?
Granulocyte Colony-Stimulating Factor
1
2013
23
0.100
Why?
Ascites
1
2013
13
0.100
Why?
Urinary Tract
1
2013
31
0.100
Why?
Urologic Diseases
1
2013
35
0.100
Why?
Patient Discharge
1
2014
204
0.100
Why?
Comparative Effectiveness Research
1
2013
28
0.100
Why?
BRCA2 Protein
1
2013
3
0.100
Why?
BRCA1 Protein
1
2013
6
0.100
Why?
Tumor Burden
3
2017
62
0.100
Why?
Cross-Sectional Studies
2
2019
1485
0.090
Why?
Genotype
2
2012
706
0.090
Why?
Fatty Acids
1
2013
100
0.090
Why?
Genomics
1
2013
89
0.090
Why?
Anthracyclines
1
2013
52
0.090
Why?
Maximum Tolerated Dose
2
2012
62
0.090
Why?
Body Mass Index
3
2016
863
0.090
Why?
Polymorphism, Single Nucleotide
3
2014
1052
0.090
Why?
Diet
1
2014
382
0.090
Why?
Magnetic Resonance Imaging
2
2018
1211
0.090
Why?
Tissue Expansion Devices
1
2011
12
0.090
Why?
Immunotherapy, Active
1
2011
7
0.090
Why?
Evidence-Based Medicine
1
2013
212
0.090
Why?
Clinical Trials, Phase III as Topic
1
2011
27
0.090
Why?
Clinical Competence
1
2014
329
0.090
Why?
Chi-Square Distribution
3
2009
287
0.090
Why?
Immunoenzyme Techniques
3
2015
47
0.090
Why?
Genes, BRCA1
1
2011
8
0.090
Why?
Diabetes Mellitus
1
2014
390
0.090
Why?
Oligonucleotide Array Sequence Analysis
1
2012
160
0.090
Why?
Heterozygote
1
2011
60
0.090
Why?
Case-Control Studies
5
2014
858
0.090
Why?
Sleep
1
2012
87
0.080
Why?
Nucleic Acid Amplification Techniques
1
2011
10
0.080
Why?
Pancreatitis
1
2011
20
0.080
Why?
Organizational Objectives
1
2010
27
0.080
Why?
Poverty
2
2008
105
0.080
Why?
Phenotype
1
2012
619
0.080
Why?
Cooperative Behavior
1
2010
83
0.080
Why?
Patient Satisfaction
1
2011
230
0.080
Why?
Research Design
1
2012
316
0.080
Why?
Tomography, X-Ray Computed
3
2018
906
0.080
Why?
Smoking
2
2017
505
0.080
Why?
Cost-Benefit Analysis
1
2010
191
0.070
Why?
Fluorouracil
4
2012
79
0.070
Why?
Equipment Design
2
2007
177
0.070
Why?
Medical Records
4
2012
75
0.070
Why?
Protein Biosynthesis
1
2009
42
0.070
Why?
Immunotherapy
2
2019
91
0.070
Why?
Hysterectomy
1
2009
52
0.070
Why?
Multifactorial Inheritance
1
2008
24
0.070
Why?
Aryl Hydrocarbon Hydroxylases
1
2008
6
0.070
Why?
Glutathione S-Transferase pi
1
2008
9
0.070
Why?
Comorbidity
3
2017
563
0.070
Why?
Models, Genetic
1
2008
93
0.070
Why?
Glutathione Transferase
1
2008
25
0.070
Why?
Telomere
1
2008
11
0.070
Why?
Radiation Tolerance
1
2008
27
0.070
Why?
Ascitic Fluid
1
2007
4
0.070
Why?
Perfusion
2
2020
75
0.070
Why?
Paclitaxel
3
2013
57
0.060
Why?
Leg
1
2007
67
0.060
Why?
Neoplasm Proteins
3
2017
146
0.060
Why?
Radiation Injuries
1
2008
85
0.060
Why?
Neck
1
2007
32
0.060
Why?
Health Surveys
1
2007
175
0.060
Why?
NAD
1
2007
28
0.060
Why?
Hematologic Diseases
1
2007
20
0.060
Why?
Cell Death
1
2007
74
0.060
Why?
Sequence Analysis, DNA
2
2017
135
0.060
Why?
Exercise
1
2011
605
0.060
Why?
Neutropenia
2
2008
24
0.060
Why?
Health Promotion
1
2009
242
0.060
Why?
Carcinoembryonic Antigen
1
2006
8
0.060
Why?
False Negative Reactions
1
2006
22
0.060
Why?
Patient Participation
1
2007
90
0.060
Why?
Keratins
1
2006
39
0.060
Why?
Rupture
1
2006
33
0.060
Why?
Dose-Response Relationship, Drug
2
2012
709
0.060
Why?
Telomerase
1
2006
20
0.060
Why?
Fluorescent Dyes
1
2006
52
0.060
Why?
Survival
1
2006
13
0.060
Why?
Continental Population Groups
1
2007
228
0.060
Why?
Endosonography
1
2006
55
0.060
Why?
Suture Techniques
1
2006
60
0.060
Why?
International Agencies
2
2017
10
0.050
Why?
Drug Administration Schedule
3
2012
276
0.050
Why?
Hemangioma, Cavernous
1
2004
3
0.050
Why?
Nevus
1
2004
17
0.050
Why?
Malignant Carcinoid Syndrome
1
2003
1
0.050
Why?
Gene Amplification
1
2003
9
0.050
Why?
Anoikis
1
2003
1
0.050
Why?
Tropomyosin
1
2003
9
0.050
Why?
Monitoring, Intraoperative
1
2004
40
0.050
Why?
Regression Analysis
1
2004
273
0.050
Why?
Hyperplasia
1
2003
36
0.050
Why?
In Situ Hybridization, Fluorescence
1
2003
43
0.050
Why?
Carcinoma, Neuroendocrine
1
2003
14
0.050
Why?
Hypercalcemia
1
2003
12
0.050
Why?
Massage
1
2003
8
0.050
Why?
Preoperative Period
2
2014
30
0.050
Why?
Flow Cytometry
1
2003
184
0.050
Why?
Drosophila Proteins
1
2003
47
0.050
Why?
Cell Biology
1
2002
2
0.050
Why?
Specimen Handling
1
2002
31
0.050
Why?
Cryopreservation
1
2002
52
0.050
Why?
Recombinant Proteins
1
2003
263
0.050
Why?
Polymerase Chain Reaction
3
2008
189
0.040
Why?
Image Processing, Computer-Assisted
1
2003
232
0.040
Why?
DNA Mutational Analysis
1
2020
70
0.040
Why?
Personnel, Hospital
1
2020
12
0.040
Why?
Infection Control
1
2020
26
0.040
Why?
Appointments and Schedules
1
2019
21
0.040
Why?
Ohio
1
2019
63
0.040
Why?
Vulnerable Populations
1
2019
37
0.040
Why?
Health Plan Implementation
1
2019
18
0.040
Why?
Tissue Fixation
1
2019
13
0.040
Why?
Propensity Score
1
2019
47
0.040
Why?
Paraffin Embedding
1
2019
12
0.040
Why?
Triage
1
2020
68
0.040
Why?
Formaldehyde
1
2019
15
0.040
Why?
Remission Induction
2
2010
94
0.040
Why?
Surgical Procedures, Operative
1
2020
78
0.040
Why?
Pancreatic Diseases
1
2019
21
0.040
Why?
Program Evaluation
1
2019
171
0.040
Why?
Single-Blind Method
2
2011
192
0.040
Why?
Hospital Costs
1
2019
48
0.030
Why?
Socioeconomic Factors
1
2019
388
0.030
Why?
Reference Values
1
2018
238
0.030
Why?
Cell Survival
1
2018
286
0.030
Why?
Intestine, Small
1
2018
44
0.030
Why?
ROC Curve
1
2018
169
0.030
Why?
Pathology, Molecular
1
2017
15
0.030
Why?
Intention to Treat Analysis
1
2017
25
0.030
Why?
Genes, erbB-1
1
2017
14
0.030
Why?
Clone Cells
1
2017
35
0.030
Why?
DNA-Binding Proteins
2
2011
149
0.030
Why?
Genes, Neoplasm
1
2017
17
0.030
Why?
Genes, ras
1
2017
26
0.030
Why?
Healthcare Disparities
1
2019
180
0.030
Why?
Tumor Suppressor Protein p53
1
2017
80
0.030
Why?
Protein Kinase Inhibitors
1
2017
90
0.030
Why?
Neoplastic Stem Cells
1
2017
93
0.030
Why?
Diarrhea
2
2008
72
0.030
Why?
Heart Diseases
1
2017
114
0.030
Why?
Pancreatic Fistula
1
2016
4
0.030
Why?
Postoperative Period
1
2016
95
0.030
Why?
Abdomen
1
2016
44
0.030
Why?
Hospitalization
1
2019
476
0.030
Why?
Chemoprevention
1
2015
11
0.030
Why?
Platelet Count
1
2015
23
0.030
Why?
Lymphocyte Count
1
2015
25
0.030
Why?
Hydrocortisone
1
2015
64
0.030
Why?
Neoplasms, Second Primary
1
2015
24
0.030
Why?
Signal Transduction
1
2019
716
0.030
Why?
Shock, Septic
1
2015
26
0.030
Why?
Stomach
1
2015
19
0.030
Why?
Lung Diseases
1
2015
50
0.030
Why?
Blood Loss, Surgical
1
2015
50
0.030
Why?
Cause of Death
1
2015
236
0.030
Why?
Spleen
1
2015
82
0.030
Why?
Ultrasonography
1
2017
394
0.030
Why?
Analysis of Variance
1
2015
470
0.030
Why?
Pancreas
1
2015
107
0.030
Why?
Colon
1
2015
73
0.030
Why?
beta Carotene
1
2014
6
0.030
Why?
Folic Acid Deficiency
1
2014
2
0.030
Why?
Chemoembolization, Therapeutic
1
2014
10
0.030
Why?
Folic Acid
1
2014
11
0.030
Why?
Pneumonia
1
2014
62
0.030
Why?
Serum Albumin
1
2014
55
0.030
Why?
Malnutrition
1
2014
21
0.030
Why?
Omentum
1
2014
25
0.030
Why?
Micronutrients
1
2014
21
0.030
Why?
Prevalence
1
2017
960
0.030
Why?
Thrombosis
1
2014
78
0.030
Why?
Zinc
1
2014
29
0.030
Why?
Respiratory Insufficiency
1
2014
60
0.030
Why?
Receptors, Estrogen
1
2014
104
0.030
Why?
Mice
1
2019
2544
0.030
Why?
Arrhythmias, Cardiac
1
2014
100
0.030
Why?
Energy Intake
1
2014
121
0.020
Why?
Ovariectomy
1
2014
202
0.020
Why?
Cyclophosphamide
1
2013
37
0.020
Why?
American Recovery and Reinvestment Act
1
2013
1
0.020
Why?
Societies, Scientific
1
2013
16
0.020
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2013
5
0.020
Why?
Research Support as Topic
1
2013
32
0.020
Why?
National Cancer Institute (U.S.)
1
2013
21
0.020
Why?
Doxorubicin
1
2013
73
0.020
Why?
Liver
1
2015
491
0.020
Why?
Carcinoma, Non-Small-Cell Lung
1
2013
108
0.020
Why?
Surgery, Plastic
1
2012
29
0.020
Why?
Physician's Role
1
2012
41
0.020
Why?
Europe
1
2012
82
0.020
Why?
Multicenter Studies as Topic
1
2012
110
0.020
Why?
Physical Therapy Modalities
1
2011
81
0.020
Why?
Nuclear Proteins
1
2011
74
0.020
Why?
Cell Cycle Proteins
1
2011
52
0.020
Why?
Cell Line, Tumor
1
2013
726
0.020
Why?
Platinum Compounds
1
2010
3
0.020
Why?
Patient Compliance
1
2011
206
0.020
Why?
Contrast Media
1
2010
136
0.020
Why?
Patient Education as Topic
1
2011
245
0.020
Why?
Temperature
1
2010
58
0.020
Why?
Sex Factors
1
2011
656
0.020
Why?
Colonic Polyps
1
2008
17
0.020
Why?
Polymorphism, Single-Stranded Conformational
1
2008
6
0.020
Why?
Infusions, Intravenous
1
2008
97
0.020
Why?
Dose-Response Relationship, Radiation
1
2008
82
0.020
Why?
DNA Primers
1
2008
85
0.020
Why?
Patient Care
1
2008
28
0.020
Why?
Radiation Dosage
1
2008
90
0.020
Why?
Probability
1
2008
154
0.020
Why?
Confidence Intervals
1
2008
141
0.020
Why?
Administration, Oral
1
2008
201
0.020
Why?
Alleles
1
2008
250
0.020
Why?
National Institutes of Health (U.S.)
1
2007
31
0.020
Why?
Base Sequence
1
2008
256
0.020
Why?
Gender Identity
1
2007
28
0.020
Why?
SEER Program
1
2007
38
0.020
Why?
Leucovorin
1
2007
19
0.020
Why?
Drainage
1
2007
65
0.020
Why?
Sex Distribution
1
2007
174
0.020
Why?
Age Distribution
1
2007
194
0.020
Why?
Observer Variation
1
2006
96
0.010
Why?
Vacuum
1
2006
23
0.010
Why?
Thrombocytopenia
1
2005
30
0.010
Why?
Gastrointestinal Diseases
1
2005
51
0.010
Why?
Fatigue
1
2005
80
0.010
Why?
Blood Vessel Prosthesis Implantation
1
2005
61
0.010
Why?
Wound Healing
1
2006
180
0.010
Why?
S100 Proteins
1
2004
20
0.010
Why?
Polymorphism, Restriction Fragment Length
1
2003
10
0.010
Why?
Antigens, Neoplasm
1
2004
38
0.010
Why?
Protein Isoforms
1
2003
60
0.010
Why?
Genes, Tumor Suppressor
1
2003
32
0.010
Why?
Cell Transformation, Neoplastic
1
2003
60
0.010
Why?
Stereotaxic Techniques
1
2003
23
0.010
Why?
Tumor Suppressor Proteins
1
2003
64
0.010
Why?
Patient Care Planning
1
2004
55
0.010
Why?
Down-Regulation
1
2003
131
0.010
Why?
Postoperative Care
1
2003
79
0.010
Why?
Tamoxifen
1
2002
59
0.010
Why?
RNA, Messenger
1
2003
499
0.010
Why?
Gene Expression Regulation
1
2003
478
0.010
Why?
Levine's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (567)
Explore
_
Co-Authors (56)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_